Michael L Goris
Affiliation: Stanford University
- A critical discussion of computer analysis in medical imagingMichael L Goris
Division of Nuclear Medicine, Stanford University School of Medicine, Stanford, CA 94305 5281, USA
Proc Am Thorac Soc 4:347-9. 2007..However, in the context of trials, the validation may come from a superior ability to detect objective change and to discriminate between affected and unaffected individuals...
- Sampling density for the quantitative evaluation of air trappingMichael L Goris
Division of Nuclear Medicine H0101, Stanford University School of Medicine, Stanford, CA, 94305 5281, USA
Pediatr Radiol 39:221-5. 2009..To reduce the dose one can change the CT acquisition settings or decrease the sampling density...
- An automated approach to quantitative air trapping measurements in mild cystic fibrosisMichael L Goris
Division of Nuclear Medicine Radiology, Stanford University, CA 94305, USA
Chest 123:1655-63. 2003..To automatically derive the degree of air trapping in mild cystic fibrosis (CF) disease from high-resolution CT (HRCT) data, and to evaluate the discriminating power of the measurement...
- Perspectives of molecular imaging and radioimmunotherapy in lymphomaAndrei Iagaru
Department of Radiology, Division of Nuclear Medicine, Stanford University Medical Center, 300 Pasteur Drive, Room H 0101, Stanford, CA 94305 5427, USA
Radiol Clin North Am 46:243-52, viii. 2008..Finally, we discuss advances in molecular imaging that may herald the next generation of PET radiotracers after 18F FDG...
- (18)F-FDG-PET/CT evaluation of response to treatment in lymphoma: when is the optimal time for the first re-evaluation scan?Andrei Iagaru
Division of Nuclear Medicine, Stanford University Medical Center, 300 Pasteur Dr, Room H 0101, Stanford, CA 94305 5427, USA
Hell J Nucl Med 11:153-6. 2008..80 in group B. Results of PET/CT after 2 cycles of chemotherapy did not statistically differ from the results of PET/CT after 4 cycles of chemotherapy. These results need to be confirmed in larger, prospective, randomized trials...
- 90Y-ibritumomab therapy in refractory non-Hodgkin's lymphoma: observations from 111In-ibritumomab pretreatment imagingAndrei Iagaru
Division of Nuclear Medicine, Stanford University Medical Center, Stanford, California 94305, USA
J Nucl Med 49:1809-12. 2008..90Y-ibritumomab is an antibody targeting CD20 receptors on the surface of lymphocytes. We present observations from our clinical experience with 90Y-ibritumomab in the management of NHL...
- Relative lung perfusion distribution in normal lung scans: observations and clinical implicationsChristopher P Cheng
Department of Mechanical Engineering, Stanford University, Stanford, CA, USA
Congenit Heart Dis 1:210-6. 2006..These values of normal relative perfusion will be useful for establishing what is abnormal and for clinical decisions related to various pulmonary vascular diseases...
- Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolizationJohn D Louie
Department of Radiology, Stanford University Medical Center, CA 94305 5642, USA
J Vasc Interv Radiol 20:606-13. 2009..The present study was performed to determine if cone-beam computed tomography (CBCT) affects treatment planning as an adjunct to these conventional imaging modalities...
- 131I-Tositumomab (Bexxar) vs. 90Y-Ibritumomab (Zevalin) therapy of low-grade refractory/relapsed non-Hodgkin lymphomaAndrei Iagaru
Division of Nuclear Medicine, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, USA
Mol Imaging Biol 12:198-203. 2010..Both target CD20 receptors present on the surface of lymphocytes. We present our clinical experience with Bexxar and Zevalin in the management of low-grade refractory or relapsed NHL...
- 99mTc-HYNIC-annexin V SPECT imaging of acute stroke and its response to neuroprotective therapy with anti-Fas ligand antibodyFrancis G Blankenberg
Division of Pediatric Radiology Department of Radiology, Stanford University Hospital, 725 Welch Road, Rm 1673, Lucile Packard Children s Hospital, Palo Alto, CA 94305, USA
Eur J Nucl Med Mol Imaging 33:566-74. 2006..Secondly, we wished to test radiolabeled annexin's ability to monitor therapy in a rodent model of focal ischemic injury...
- Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease: a quantitative analysisTerry E Robinson
Department of Pediatrics Pulmonary, Pediatric Pulmonary Division, Stanford University Medical Center, 701 Welch Rd, Whelan Building, 3328, Palo Alto, CA 94305 5786, USA
Chest 128:2327-35. 2005....
- Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase studyAndrei Iagaru
Division of Nuclear Medicine, Stanford University Medical Center, Stanford, California, USA
J Nucl Med 50:501-5. 2009..Sodium (18)F was previously used for bone imaging and can be used as a PET/CT skeletal tracer. The combined administration of (18)F and (18)F-FDG in a single PET/CT study for cancer detection has not been reported to date...
- Detection of focal hypoxic-ischemic injury and neuronal stress in a rodent model of unilateral MCA occlusion/reperfusion using radiolabeled annexin VCarina Mari
Division of Nuclear Medicine, Department of Radiology, Stanford University Hospital, Stanford, CA 94305, USA
Eur J Nucl Med Mol Imaging 31:733-9. 2004..This pattern suggests that neuronal stress may play a role in the response of the brain to focal injury and be responsible for annexin V uptake outside the region of ischemic insult...
- Quantitative analysis of longitudinal response to aerosolized granulocyte-macrophage colony-stimulating factor in two adolescents with autoimmune pulmonary alveolar proteinosisTerry E Robinson
Center of Excellence in Pulmonary Biology, Division of Pediatric Pulmonary, Stanford University Medical Center, 770 Welch Road, Stanford, CA 94305 5715, USA
Chest 135:842-8. 2009..Aerosolized GM-CSF therapy (aeroGM-SCF) has qualitatively improved the clinical condition of patients with APAP. This report details quantitative chest CT responses to aeroGM-CSF...
- Phase I study of 131I-chimeric(ch) TNT-1/B monoclonal antibody for the treatment of advanced colon cancerHilary Hardy Street
Department of Radiation Oncology, Stanford University, Stanford, CA 943053, USA
Cancer Biother Radiopharm 21:243-56. 2006..The rationale for targeting areas of tumor necrosis is the observation that necrotic lesions are more abundant in cancer lesions than in surrounding tissues...
- Evaluation of herpes simplex virus 1 thymidine kinase-mediated trapping of (131)I FIAU and prodrug activation of ganciclovir as a synergistic cancer radio/chemotherapyMeike L Schipper
Molecular Imaging Program at Stanford MIPS, Department of Radiology and Bio X Program, Stanford University, Palo Alto, CA 94305 5427, USA
Mol Imaging Biol 9:110-6. 2007..Evaluation of selective killing of Herpes Simplex Virus 1 thymidine kinase (HSV1-tk) expressing tumors by radiolabeled (131)I-fialuridine (FIAU), and of synergy between (131)I-FIAU and Ganciclovir (GCV)...
- Positively labeled white blood cell scan with eosinophilia and absence of infectionMinal S Vasanawala
Division of Nuclear Medicine, Stanford University, California 94305, USA
Clin Nucl Med 28:389-91. 2003..The authors describe the variability of Tc-99m exametazime-labeled leukocyte distribution as a function of the relative frequency of white cell types in the labeled blood...
- Monitoring the protective effects of minocycline treatment with radiolabeled annexin V in an experimental model of focal cerebral ischemiaXian Nan Tang
Department of Neurology, University of California San Francisco, San Francisco, CA 94121, USA
J Nucl Med 48:1822-8. 2007..We now explore the feasibility of using (99m)Tc-annexin V, an in vivo marker of apoptosis, with SPECT to monitor the antiapoptotic effects of minocycline therapy...
- Calculation of ejection fraction in gated SPECTMichael L Goris
J Nucl Med 44:657; author reply 657. 2003